Cover Image
市場調查報告書

美國的學名藥市場:產業趨勢、競爭情形、機會、預測

US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook

出版商 IMARC Services Pvt. Ltd. 商品編碼 356079
出版日期 內容資訊 英文 51 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的學名藥市場:產業趨勢、競爭情形、機會、預測 US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook
出版日期: 2016年03月23日 內容資訊: 英文 51 Pages
簡介

本報告提供美國的學名藥市場相關調查分析,過去、目前趨勢,未來預測為焦點,銷售額趨勢,數量趨勢,成長率,主要市場區隔,競爭結構,法規,主要製造商等系統性資訊。

第1章 調查手法與市場定義

第2章 報告摘要

第3章 美國的學名藥市場:簡介

第4章 美國的學名藥市場有利的理由

  • 暢銷藥物的專利失效
  • 學名藥和創新者醫藥品的大幅度的價差
  • 政府/第三方付款者的節約
  • 學名藥的調劑、處方的獎勵
  • 償付與低自我負擔額
  • 生技仿製藥

第5章 全球學名藥市場

  • 現在、過去的市場趨勢
  • 市場明細 (各國) :美國全球最大的市場
  • 市場預測

第6章 美國的學名藥市場

  • 美國的醫藥品市場:現在、過去的市場趨勢
  • 美國的醫藥品市場:品牌/學名藥的佔有率
  • 美國的學名藥市場:現在、過去的銷售額趨勢
  • 美國的學名藥市場:現在、過去的數量趨勢
  • 美國的學名藥市場:市場明細 (各市場區隔)

第7章 美國的學名藥市場:競爭情形

  • 美國的學名藥市場:競爭結構
  • 美國的學名藥市場:主要企業的銷售額的明細
  • 美國的學名藥市場:主要企業的數量的明細
  • 美國的學名藥市場:最被處方的學名藥
  • 美國的學名藥市場:市場明細 (各流通管道)
  • 美國的學名藥市場:價格趨勢

第8章 美國的學名藥市場:價值鏈分析

  • 研究、開發
  • 製造
  • 行銷、流通

第9章 美國的學名藥產業的法規

  • 藥事法規概要
  • 醫藥品申請
  • 專利與市場優先權
  • 學名藥的法律上的要求事項
  • 哈奇 - 維克斯曼法案
  • 可能的證明
  • 其他重要事項

第10章 美國的學名藥市場:成功因素

第11章 美國的學名藥市場:障礙

第12章 學名藥製造工廠建設的必要條件

  • 製造工程
  • 原料必要條件
  • 機器、基礎設施必要條件

第13章 美國的學名藥市場:主要企業簡介

  • Teva
  • Mylan
  • Actavis
  • Sandoz
  • Sun Pharma
  • Par Pharmaceuticals
  • Endo Pharmaceuticals
  • Lupin Pharmaceuticals
  • Dr Reddy's
  • Hospira

圖表

目錄
Product Code: SRP00116CL

The US generics market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generics now account for the majority of the total prescriptions dispensed in the United States. During 2010-2015, the US generics market grew at a CAGR of more than 11% and currently represent a multibillion dollar industry. The biggest catalyst of this industry is the significantly lower price of generics compared to branded drugs. Although generics are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. This has enabled governments and third-party payers to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Other factors such as patent expiration of blockbuster innovator drugs, ageing population and an increasing prevalence of chronic diseases have also acted as catalysts for this market.

The report entitled “US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” provides a comprehensive insight into the historical and current trends as well as the future prospects of the US generics market. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments, competitive structure, regulations, major manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future prospects of the US generics market. This report can serve as an excellent guide for manufacturers, consultants, researchers, marketing strategists and all those who plan to foray into the US generics market in any form.

What We Have Achieved in This report?

  • Historical, current and future sales trends in the US generics market
  • Historical, current and future prescription trends in the US generics market
  • Performance of the US generics market compared to the pharmaceutical market
  • Performance of the US generics market compared to other major markets
  • Market structure of the US generics market
  • Competitive landscape in the US generics market
  • Top US generic drug manufacturers and their market shares
  • Distribution of generics in the US
  • Top US generic distributors and their market shares
  • Most prescribed generic drugs in the US
  • Pricing analysis of generic drugs
  • Value chain analysis of generic drugs in the US
  • Regulations in the US generics market
  • Manufacturing process of generics
  • Machinery and raw material requirements for manufacturing generics
  • Key success and risk factors in the US generics market

Table of Contents

1. Research Methodology and Market Definitions

2. Report Summary

3. US Generics Market - Introduction

  • 3.1. What are Generics?
  • 3.2. Unbranded and Branded Generics
  • 3.3. Authorized Generics
  • 3.4. Commoditised and Specialty Generics

4. Why is the US Generics Market so Lucrative

  • 4.1. Patent Expiry of Blockbuster Drugs
  • 4.2. Significant Price Differential Between Generics and Innovator Drugs
  • 4.3. Savings for the Government and Third Party Payers
  • 4.4. Incentives for Dispensing and Prescribing Generics
  • 4.5. Reimbursement and Lower Copayments
  • 4.6. Biosimilars

5. Global Generics Market

  • 5.1. Current and Historical Market Trends
  • 5.2. Market Breakup by Country: The United States Represents the World's Biggest Market
  • 5.3. Market Forecast

6. US Generics Market

  • 6.1. US Pharmaceutical Market - Current and Historical Market Trends
  • 6.2. US Pharmaceutical Market - Share of Branded and Generic Drugs
  • 6.3. US Generics Market - Current and Historical Sales Trends
  • 6.4. US Generics Market - Current and Historical Volume Trends
  • 6.5. US Generics Market - Market Breakup By Segment

7. US Generics Market- Competitive Landscape

  • 7.1. US Generics Market - Competitive Structure
  • 7.2. US Generics Market - Sales Breakup of Key Players
  • 7.3. US Generics Market - Volume Breakup of Key Players
  • 7.4. US Generics Market - Most Prescribed Generic Drugs
  • 7.5. US Generics Market - Market Breakup By Distribution
  • 7.6. US Generics Market - Pricing Dynamics

8. US Generics Market - Value Chain Analysis

  • 8.1. Research and Development
  • 8.2. Manufacturing
  • 8.3. Marketing and Distribution

9. Regulations in the US Generics Industry

  • 9.1. Overview of Pharmaceutical Regulations
  • 9.2. Drug Applications
  • 9.3. Patents and Market Exclusivity
  • 9.4. Regulatory Requirement For Generics
  • 9.5. The Hatch-Waxman Act
  • 9.6. Possible Certifications
  • 9.7. Other Important Considerations

10. US Generics Market: Key Success Factors

11. US Generics Market: Road Blocks

12. Requirements for Setting Up a Generic Drug Manufacturing Plant

  • 12.1. Manufacturing Process
  • 12.2. Raw Material Requirements
  • 12.3. Machinery and Infrastructure Requirements

13. US Generic Market - Key Company Profiles

  • 13.1. Teva
  • 13.2. Mylan
  • 13.3. Actavis
  • 13.4. Sandoz
  • 13.5. Sun Pharma
  • 13.6. Par Pharmaceuticals
  • 13.7. Endo Pharmaceuticals
  • 13.8. Lupin Pharmaceuticals
  • 13.9. Dr Reddy's
  • 13.10. Hospira

List of Figures

  • Figure 3-1: Structure of the Pharmaceutical Industry
  • Figure 3-2: Classification of Generics
  • Figure 4-1: United States: Patent Expiry Exposure (in Billion US$)
  • Figure 4-2: United States: Savings From Generic Drugs (in Billion US$), 2005-2015
  • Figure 5-1: Global: Generics Market: Sales Value (in Billion US$), 2011-2015
  • Figure 5-2: Global: Generics Market: Sales Volume (in Billion SU), 2011-2015
  • Figure 5-3: Global: Generics Market: Sales Value Breakup By Country (in %), 2015
  • Figure 5-4: Global: Generics Market: Sales Volume Breakup by Country (in %), 2015
  • Figure 5-5: Global: Generics Market Forecast: Sales Value (in Billion US$), 2016-2021
  • Figure 5-6: Global: Generics Market: Sales Volume (in Billion SU), 2016-2021
  • Figure 6-1: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2011-2015
  • Figure 6-2: US: Pharmaceutical Market: Sales Value (in US$ Billion), 2011-2015
  • Figure 6-3: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2011 & 2015
  • Figure 6-4: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2011 & 2015
  • Figure 6-5: US: Generics Market: Sales Value (in Billion US$), 2011-2015
  • Figure 6-6: US: Generics Market Forecast: Sales Value (in US$ Billion), 2016-2021
  • Figure 6-7: US: Generics Market: Sales Volume (in Million Prescriptions), 2011-2015
  • Figure 6-8: US: Generics Market Forecast: Sales Volume (in Million Prescriptions), 2016-2021
  • Figure 6-9: US: Generics Market: Market Breakup by Segment (in %), 2011-2015
  • Figure 7-1: United States: Generics Market: Sales Share of Top Players (in %), 2015
  • Figure 7-2: United States: Generics Market: Volume Share of Top Players (in %), 2015
  • Figure 7-3: United States: Generics Market: Volume Share by Distribution (in %), 2015
  • Figure 7-4: United States: Generic Drug Prices as a Percentage of Branded Drug Prices - Based on Number of Competitors (in Billion US$)
  • Figure 8-1: United States - Generics Market - Value Chain Analysis

List of Tables

  • Table 4-1: United States: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
  • Table 5-1: Global - Generics Market: Sales, Volume and Growth of Major Markets, 2015
  • Table 7-1: United States: Generics Market: Sales Performance of Top Players (in US$ Million), 2015
  • Table 7-2: United States: Generics Market: Volume Performance of Top Players (in Million Prescriptions), 2015
  • Table 7-3: United States: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2015
  • Table 9-1: United States: Overview of Pharmaceutical Regulations
Back to Top